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Biophysics, University of North Carolina, Chapel Hill, North CarolinaABSTRACT Small angle x-ray diffraction revealed a strong influence of the N-terminal influenza hemagglutinin fusion peptide
on the formation of nonlamellar lipid phases. Comparative measurements were made on a series of three peptides, a 20-residue
wild-type X-31 influenza virus fusion peptide, GLFGAIAGFIENGWEGMIDG, and its two point-mutant, fusion-incompetent
peptides G1E and G13L, in mixtures with hydrated phospholipids, either dipalmitoleoylphosphatidylethanolamine (DPoPE),
or monomethylated dioleoyl phosphatidylethanolamine (DOPE-Me), at lipid/peptide molar ratios of 200:1 and 50:1. All three
peptides suppressed the HII phase and shifted the La–HII transition to higher temperatures, simultaneously promoting formation
of inverted bicontinuous cubic phases, QII, which becomes inserted between the La and HII phases on the temperature scale.
Peptide-induced QII had strongly reduced lattice constants in comparison to the QII phases that form in pure lipids. QII formation
was favored at the expense of both La and HII phases. The wild-type fusion peptide, WT-20, was distinguished from G1E and
G13L by the markedly greater magnitude of its effect. WT-20 disordered the La phase and completely abolished the HII phase in
DOPE-Me/WT-20 50:1 dispersions, converted the QII phase type from Im3m to Pn3m and reduced the unit cell size from ~38 nm
for the Im3m phase of DOPE-Me dispersions to ~15 nm for the Pn3m phase in DOPE-Me/WT-20 peptide mixtures. The strong
reduction of the cubic phase lattice parameter suggests that the fusion-promoting WT-20 peptide may function by favoring
bilayer states of more negative Gaussian curvature and promoting fusion along pathways involving Pn3m phase-like fusion
pore intermediates rather than pathways involving HII phase-like intermediates.INTRODUCTIONViral fusion proteins are known to contain segments of
10–30 mostly nonpolar residues, so-called fusion peptides
(FPs), which insert into the host cell membrane at an early
stage of fusion. According to the consensus picture, their
insertion is associated with a sequence of events, involving
viral protein conformational transitions, which finally result
in merging of the viral membrane into the target membrane
(1). Although this picture suggests that FPs serve to attach
the viral protein to the host membrane, this does not appear
to be their only function. In vitro studies have typically
proposed that FPs alone, at sufficiently high peptide/lipid
ratios display an ability to promote membrane rupture or
fusion (2–8). More specifically, the wild-type fusion peptide
(WT-20) from X-31 influenza virus hemagglutinin fusion
protein (HA) does not induce fusion in phosphatidylcholine
vesicles but does promote polyethylene glycol (PEG)-medi-
ated fusion (9). At high peptide/lipid ratios (> ~1/200) in
the absence of PEG, the peptide promoted aggregation,
rupture, and formation of a precipitate. Despite advances
in determination of the membrane localization and confor-
mation of FPs (10), the mechanisms by which such peptides
render the bilayers more fusogenic are unclear. It is often
said that the HA FP destabilizes or perturbs the lipid bila-Submitted August 17, 2012, and accepted for publication December 17,
2012.
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insight.
Insertion of peptides into a membrane may affect its
curvature. Indeed, studies with a number of small FPs
have shown that these peptides have an impact on the
lamellar-inverted hexagonal (La–HII) transition tempera-
ture and may induce formation of isotropic phases (detected
by NMR) or cubic phases (detected by x-ray diffraction
(XRD)) (11–19). A possible interpretation of these results
is that membranes could acquire negative curvature in the
presence of FPs, and that FPs may thus facilitate formation
of curved stalks that develop into fusion pores. Unsolved
problems and ambiguities nevertheless still prevail. A quan-
titative description of how FPs affect the stabilities of the
different inverted phases, both among themselves and rela-
tive to the lamellar phase, is still lacking and this circum-
stance by itself is sufficient to preclude further insights
into the mode of action of these peptides.
There is evidence that conversion of lamellar to inverted
bicontinuous cubic phase proceeds via intermediates that
are expected to be isomorphous to fusion pores (Fig. 1
(20)). Based on this similarity, we consider the transforma-
tion from lamellar into inverted bicontinuous cubic phase
as a generic model of fusion pore formation. Although a
lamellar phase consists of multiple, separate bilayers, the bi-
continuous cubic phase consists of a single bilayer draped
along an infinite periodic minimal surface (IPMS). It is
thus obvious that a lamellar-to-bilayer cubic phase transi-
tion actually involves multiple membrane fusion events.http://dx.doi.org/10.1016/j.bpj.2012.12.034
FIGURE 1 The modified stalk mechanism of membrane fusion and in-
verted phase formation. (A) Planar lamellar (La) phase bilayers; (B) the
stalk intermediate; the stalk is cylindrically symmetrical about the dashed
vertical axis; (C) the TMC (trans monolayer contact) or hemifusion struc-
ture; the TMC can rupture to form a fusion pore, referred to as interlamellar
attachment, ILA (D); (E) If ILAs accumulate in large numbers, they can
rearrange to form QII phases. (F) For systems close to the La/HII phase
boundary, TMCs can also aggregate to form HII precursors and assemble
into HII domains (reproduced from (20) with permission).
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clarify the effect of fusion peptides on lipid transformations
from lamellar into nonlamellar phases such as hexagonal
and/or bicontinuous cubic phases. In this investigation we
applied time-resolved XRD to characterize the effects of
a series of three peptides, the wild-type N-terminal influenza
hemagglutinin fusion peptide (WT-20) and two of its
mutants, G1E and G13L, on the phase behavior of phospho-
lipids known to display lamellar-to-nonlamellar phase trans-Biophysical Journal 104(5) 1029–1037formations. We show here that all three peptides promote
formation of inverted cubic phase at the expense of the adja-
cent lamellar and inverted hexagonal phases, but that the
effect of the wild-type peptide is much stronger than that
of the two mutants.MATERIALS AND METHODS
Three 20-residue peptides were used, the wild-type N-terminal influenza
X-31 hemagglutinin fusion peptide, GLFGAIAGFIENGWEGMIDG and
the mutant peptides G1E and G13L, with sequences ELFGAIAGFIENG
WEGMIDG and GLFGAIAGFIENLWEGMIDG, respectively. The pep-
tides, with a purity of >90%, were synthesized at the peptide facility of
the University of North Carolina, Chapel Hill, as described elsewhere (9).
The phospholipids dipalmitoleoylphosphatidylethanolamine (DPoPE) and
monomethylated dioleoyl phosphatidylethanolamine (DOPE-Me) were
purchased from Avanti Polar Lipids and used as received. Both lipids
were pure as judged by thin layer chromatography and displayed phase
transitions in accord with published data. Lipid/peptide mixtures were
prepared by mixing lipid solutions in chloroform with peptide solutions
in dimethyl sulfoxide (DMSO). The solvents were removed by drying
with argon, followed by extensive high-vacuum evacuation for 72 h, as
necessary for complete removal of DMSO. The dry lipid/peptide films
were hydrated in phosphate buffered saline (PBS), pH 7.2, or citrate buffer,
pH 5, and homogenized by a succession of five freeze-thaw cycles between
dry ice and room temperature, accompanied by vortexing during thawing.
The lipid concentration in the dispersion was 10% (w/v). After their prep-
aration, the lipid/peptide dispersions were stored at 4C overnight and
equilibrated at room temperature for several hours before the x-ray mea-
surements. The samples were vortexed and loaded into x-ray capillaries
immediately before their measurement.X-ray measurements
Low-angle XRD patterns were recorded at stations 5IDD, DND-CAT, and
18D, BioCAT, APS, Argonne National Laboratory, using two-dimensional
2048  2048 MAR detectors at a sample-to-detector distance of ~200 cm.
Spacings were determined from axially integrated two-dimensional images
using the Fit2D program (21) and silver behenate as a calibration standard
(d-spacing 5.838 nm (22)). Raw data are presented and no smoothing and
background subtraction procedures have been applied. A temperature-
controlled capillary sample holder was used. All measurements were
started at 20C. The exposure times for collection of the XRD patterns
were in the range of 0.7–1 s. About 20–40 consecutive patterns were re-
corded to monitor the phase conversions. In this way, the irradiation times
during the heating scan were limited to a total of 30–40 s. These times were
several times shorter than the exposures of a few minutes needed to cause
observable radiation damage in lipid dispersions under our experimental
conditions.
Temperature protocols were executed directly on samples mounted on
the beam line, and it was thus possible to follow in real time the phase
conversions taking place in the lipid peptide dispersions. The sample holder
was mounted on a remotely controlled motorized stage and, by moving the
stage with respect to the incident x-ray beam, x-ray patterns could be re-
corded from different parts of the same sample. Such measurements—
routinely made before and after the temperature scans—showed that the
patterns recorded were representative of the entire sample volumes and
that there were no systematic differences between irradiated and nonirradi-
ated portions of the sample. Comparisons with dark samples subjected to
the same temperature protocols, for which only the initial and final states
were recorded, also confirmed the lack of radiation damage effects. On
the basis of these tests, we consider the results reported here as not influ-
enced by radiation damage of the lipid.
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In addition to the lamellar liquid crystalline La and inverted
hexagonal HII phases, fully hydrated DPoPE and DOPE-Me
dispersions can also form inverted bicontinuous cubic QII
phases under appropriate temperature protocols. We use
these systems in this work to characterize the effects of
HA FP and its two mutants on the relative stability of the
lamellar and nonlamellar lipid phases. To expose more
clearly the FP effects, we used 10 wt % lipid dispersions
in which the cubic phase formation is strongly facilitated
relative to that in the more concentrated dispersions typi-
cally used in x-ray studies.Phase behavior of DPoPE/FP mixtures
In the absence of peptides, DPoPE dispersions display
a cooperative, sharp lamellar liquid crystalline-inverted
hexagonal (La / HII) phase transition at ~42
C (23). As
is generally typical for the phosphatidylethanolamines
(PEs), this transition is not fully reversible and the recovery
of the initial La phase in the backward transition is accom-
panied by the formation of a trace amount of cubic Pn3m
phase (Fig. 2 A). The x-ray data presented here show thatFIGURE 2 Sequences of XRD patterns recorded during heating-cooling scan
(A) DPoPE control (no peptide); (B) DPoPE/WT-20; (C) DPoPE/G1E; (D) DPothe FPs strongly influences the lamellar-nonlamellar trans-
formations in DPoPE. In particular, they suppress the HII
phase and promote cubic phase formation. The effects of
the wild-type peptide (WT-20) were much more pronounced
than those of the mutant peptides G1E and G13L (Figs. 2
and 3). At a lipid/peptide ratio of 50:1, WT-20 almost fully
suppressed the recovery of the La phase in the cooling tran-
sition (Figs. 2 B and 3). In contrast to the behavior of the
pure lipid, in which traces of cubic phase appear during
the cooling transition only, the DPoPE/WT-20 mixtures
formed a cubic phase even on heating, concurrently with
the La / HII phase transition (Fig. 2 B). The evolution
of the Pn3m lattice constants in a heating-cooling cycle
(Fig. 4) was typical for PE cubic phases (24). The lattice
constants decrease on heating and increase on cooling in
the temperature range of the HII phase, and level off in the
temperature range of the La phase. At the end of the temper-
ature cycle, the values of the Pn3m lattice constants for the
different peptides were in the following order: control (no
peptide) > G1E > G13L >WT-20 (Fig. 4, Table 1), indi-
cating that the peptides promoted formation of highly
curved bicontinuous cubic structures. Promotion of the
cubic phase by the FPs involved suppression of the HII
phase. The FPs noticeably broadened and shifted to highers of DPoPE/fusion peptide mixtures (heating 1C/min, cooling 3C/min).
PE/G13L. Lipid/peptide molar ratios 50:1.
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FIGURE 3 Comparison of the XRD patterns recorded at 20C from
DPoPE/fusion peptide mixtures after heating-cooling scans shown in
Fig. 2. The lattice parameters of the phases are summarized in Table 1.
TABLE 1 Lattice parameters of DPoPE and DOPE-Me
mixtures with fusion peptides at 20C
Lipid
Lipid/peptide
ratio Phasea No peptide G1E G13L WT-20
DPoPE 50:1 Initial La 4.96 4.88 4.89 4.92
(pH 7.2) Final La 4.96 4.91 4.94 4.88
Final Pn3m 16.5 15.2 14.6 14.0
DOPE-Me Initial La 6.26/6.40
b
(pH 7.2) 50:1 Final Im3m 37.5 [34.2] 37.3 [18.9]
Final Pn3m [29.3] 26.7 28.8 14.8
DOPE-Me 50:1 Im3m 38.2 34.4 30.3 20.5
(pH 5.0) Pn3m [29.8] 26.8 24.3 16.1
DOPE-Me 200:1 Im3m 37.5 34.7 36.1 24.2
(pH 7.2) Pn3m [29.3] 27.3 28.2 19.0
Initial and final denote values obtained before and after a heating-cooling
cycle, respectively. Lattice constants in the square brackets were calculated
using the Im3m/Pn3m lattice constant ratio of 1.28, which follows from the
Bonnet transformation between these phases (see the text for details).
aThe lattice constants of the Im3m and Pn3m vary in a range of52 nm in
different measurements.
bLa spacing of DOPE-Me dispersions at 50
C.
1032 Tenchov et al.temperatures the La / HII phase transition of DPoPE
(Fig. 5). This effect was accompanied by a slight reduction
of the La and HII spacing (Fig. 6).
In summary, the FPs promoted Pn3m phase formation and
suppressed the HII phase of DPoPE. The effects of the WT-
20 peptide were much stronger than those of the mutant
peptides G1E and G13L. The magnitudes of their effects
fall in the order WT-20 > G13L > G1E.Phase behavior of DOPE-Me/FP mixtures
Due to their ability to easily form inverted cubic phases,
DOPE-Me dispersions also represent an appropriate ex-
perimental system for evaluation of the FP effects on
the lamellar-to-nonlamellar phase conversions. DOPE-Me
dispersions are known to slowly transform from the lamellar
phase into a thermodynamically stable QII phase during
incubation at constant temperature in the range ~55–60C.
Concentrated dispersions (~30 wt %) form the Pn3m phase
(25–27), whereas diluted dispersions (~10–15 wt %) form
the Im3m cubic phase (28,29), in accord with the behavior
of other PEs (24) (the unit cell of the Im3m phase is shown
in Fig. 1). The lamellar to Im3m phase transformation canFIGURE 4 Evolution of the Pn3m phase lattice parameter of DPoPE/
fusion peptide dispersions during heating-cooling cycles.
Biophysical Journal 104(5) 1029–1037also be induced in diluted DOPE-Me dispersions in a single
heating-cooling cycle (La / HII in the heating direction,
followed by HII/ Im3m in the cooling direction) carried
out at relatively fast scan rates (Fig. 7 A). Examples of these
two routes for induction of QII phases (slow conversion at
constant temperature versus heating followed by cooling)
in diluted DOPE-Me dispersions are given in our previous
work (28,29). Both methods resulted in formation of
Im3m cubic phases at ~55C with identical x-ray patterns
and similar lattice spacings, typically in the range 35–
40 nm. On this basis, it was concluded that, like the constant
temperature incubation, the cooling HII/ Im3m transition
in a heating-cooling cycle also results in formation of an
equilibrium Im3m cubic phase in 10 wt % DOPE-Me
dispersions, even though the cooling scans were performed
at relatively high scan rates of 1–5C/min (29). Once formed
at ~55C, either by La/ Im3m transition during constant
temperature incubation or by HII / Im3m transition inFIGURE 5 Upward shift of the La / HII transition in a 50:1 DPoPE/
WT-20 50:1 mixture (solid symbols) with respect to the pure DPoPE disper-
sions (open symbols).
FIGURE 6 La andHII spacings ofDPoPE(solid symbols) and50:1DPoPE/
fusion peptide mixtures: WT-20 (squares), G1E (triangles), G13L (circles).
FIGURE 7 Phase conversions during heating (1C/min) and cooling
(5C/min) of 10 wt % DOPE-Me dispersions (A) and DOPE-Me/WT-20
mixtures at molar ratios 200:1 (B) and 50:1 (A). PBS, pH 7.2. The cubic
phase lattice constants are (A) Im3m 38 nm; (B) Im3m 24.2 nm/Pn3m
19.0 nm mixture; (C) Pn3m 14.8 nm (Table 1).
Cubic Phases in Lipid/Peptide Mixtures 1033a cooling scan, the Im3m phase does not change upon cool-
ing to 20C and exists for an indefinitely long time at room
temperature (although it might actually be metastable with
respect to the La phase at the latter temperatures). DOPE-
Me thus provides a phospholipid system that appears to
achieve an equilibrium cubic phase on an experimentally
convenient timescale. Because the temperature cycle pro-
tocol is more time efficient, we chose it for characterization
of the FP effects on DOPE-Me phases.
Similar to their effects on DPoPE dispersions, FPs also
suppressed the formation of the HII phase and facilitated
cubic phase formation in DOPE-Me dispersions. The
behavior of WT-20/DOPE-Me mixtures is shown in Fig. 8,
B and C. Upon heating at a peptide/lipid molar ratio of
1:200, the La phase disappeared at 60
C, the onset of the
HII phase was shifted from ~62 to ~72
C, and an interme-
diate cubic phase with gradually decreasing lattice constant
formed in the range 60–72C. The HII phase disappeared
at 61C on cooling and was replaced by a mixture of
Im3m and Pn3m phases with lattice spacings of 24.2 and
19.0 nm, respectively, after cooling to 20C (Table 1). A
higher peptide concentration of 1:50 peptide/lipid ratio re-
sulted in disordering of the DOPE-Me La phase. However,
after heating and cooling the disordered phase became con-
verted into a well-organized Pn3m phase with a relatively
short spacing of 14.8 nm (Fig. 7 C; Table 1). No HII phase
was found to form in 1:50 peptide/lipid samples at tempera-
tures up to 80C. Again, the mutant peptides G1E and G13L
displayed weaker effects on DOPE-Me La and HII phases.
They did not dissipate the La phase, suppressed the HII phase
to a much smaller extent than did WT-20 (Fig. 8), and
produced significantly smaller reductions of the cubic phase
lattice constants (Fig. 9, Table 1). Summing up, the addition
of FPs resulted in shortening of the cubic phase lattice param-
eter and transformation of the initial Im3m phase of pureDOPE-Me with an Im3m/Pn3m mixture or a single Pn3m
phase. Because the lattice parameters of the Im3m and
Pn3m phases cannot be directly compared, to quantitate
the lattice shrinking caused by the FPs, we note that the
Im3m/Pn3m lattice parameter ratios in all cases of coexisting
Im3m and Pn3m pairs were equal with good accuracy to
1.28, in agreement with earlier observations on coexisting
cubic phases in diluted phospholipid dispersions (24), and
in compliance with the value obtained on the basis of theBiophysical Journal 104(5) 1029–1037
FIGURE 8 Phase transformations during heating (1C/min) and cooling
(5C/min) of 10 wt % DOPE-Me/G1E (A) and DOPE-Me/G13L (B)
mixtures at lipid/peptide molar ratio 50:1. The lattice constants of the final
cubic phases are given in Table 1.
FIGURE 9 Comparison of XRD patterns recorded at 20C from DOPE-
Me/fusion peptide (50:1) mixtures after heating-cooling scans. (A) pH 7.2;
(B) pH 5.0. The lattice constants of the cubic phases are summarized in
Table 1.
1034 Tenchov et al.Im3m and Pn3m representation with the primitive (P) and
diamond (D) IPMS, respectively. Considerations based on
the Bonnet transformation between these IPMS, which
involves the gyroid IPMS as an intermediate (30), or, alterna-
tively, based on a direct Im3m-Pn3m transformation pathway
proposed in (31), showed that the ratio of the unit cell dimen-
sions of the Im3m and Pn3m phases, linked by these transfor-
mations, must be equal to 1.28. We can thus use this ratio to
calculate the lattice parameter of the conjugated cubic phase
in the cases where we observed a single Im3m or Pn3m
phase. The values calculated in this way are given in square
brackets in Table 1. These values complement the experi-
mentallymeasured lattice parameters and provide a quantita-
tive measure of the reduction of the cubic phase lattice
parameters induced by the FPs.DISCUSSION
The fusion peptides all promoted formation of the QII
phase at the expense of both the La and HII phases. TheyBiophysical Journal 104(5) 1029–1037suppressed and shifted to higher temperatures the HII
phases of DPoPE and DOPE-Me, most dramatically in
the case of the WT-20 peptide, which completely abolished
the HII phase and disordered the La phase in DOPE-Me/
WT-20 50:1 dispersions (Fig. 7 C). All three peptides
reduced the unit cell sizes of the cubic phases, but the effect
of WT-20 was particularly strong. At a DOPE-Me/peptide
50:1 molar ratio, the presence of WT-20 resulted in forma-
tion of a QII phase with ~2 times smaller lattice constant
than was found in the presence of the mutant peptides
(Table 1). WT-20 converted the cubic phase type from
Im3m to Pn3m and reduced the unit cell size from
~38 nm for the Im3m phase in DOPE-Me dispersions to
~15 nm for the Pn3m phase in DOPE-Me/peptide mixtures.
The formation of inverted bicontinuous cubic structures
of smaller lattice constants in the presence of fusion
peptides implies that fusion peptides promote more nega-
tive Gaussian curvature of the lipid bilayers because the
surface-averaged Gaussian curvature in the cubic unit cell
Cubic Phases in Lipid/Peptide Mixtures 1035is proportional to 1/a2, where a is the lattice parameter of
the cubic phase (32).
The markedly different effects of WT-20 and the mutant
peptides G1E and G13L on the lipid phase behavior appear
to be consistent with differences in their molecular struc-
tures. The N-terminal segments of the influenza virus glyco-
protein HA2 domains modeled by the synthetic fusion
peptides are represented by hydrophobic, highly conserved
glycine-rich sequences. Comparisons of these sequences
in various subtypes of influenza virus strains have demon-
strated that the residues Gly-1–Glu-11, Gly-13, Trp-14,
and Gly-16 are strictly conserved (8,33–35). The Gly-1
N-terminal residue is particularly critical for the fusion
function. Substitution of glutamic acid for Gly-1 completely
abolishes HA protein fusion activity (36) and substitutions
with other amino acids, Ala, Ser, Val, Glu, Gln, or Lys,
result in substantial impairments of the fusion phenotype
(37). NMR and spin labeling studies of the WT-20 peptide
coupled at its C-terminus to NH2-GCGKKKK-CONH2
showed that it adopts an inverted V-shaped conformation
in micelles and lipid bilayers with a kink angle of 105
formed by Glu-11, Asn-12, and Gly-13 (38,39). The
C-terminal segment of the peptide forms an amphipathic
helix at the membrane interface, whereas the N-terminal
segment is deeply embedded in the hydrophobic interior
of the bilayer. Due to the highly hydrophilic nature of
Glu, one may expect that replacing Gly-1 with Glu would
result in reduced hydrophobic penetration of the N-terminus
of G1E. Another strictly conserved glycine residue, Gly-13,
is part of the short structural motif forming the kink
and stabilizing the peptide V-shaped conformation in the
membrane. A study on a set of fusion peptide sequences
suggests that substituting Gly-13 by leucine may destabilize
and eliminate the kink modifying in this way the conforma-
tion of G13L in the bilayers (8). Another G13 mutation,
G13A, was found to result in a shallower kink conformation
with a kink angle increased from 105C in the wild-type
peptide to 150C in the G13A mutant (40). It thus appears
that the unique WT-20 conformation in the membrane is
particularly important for the profound WT-20 effects on
the PE phase behavior (destabilization of the La and HII
phases in favor of QII formation and strongly reduced QII
lattice spacing), because these effects are displayed to
a much lesser extent in PE mixtures with the mutant G1E
and G13L peptides. Notably, the smaller effects of the
mutant peptides relative to WT-20 correlate with their
reduced fusion-promoting ability in PEG-mediated model
membrane fusion and reduced influence on the hydrophobic
interior of the bilayer assessed on the basis of circular
dichroism, Fourier transform infrared spectroscopy, and
fluorescence probe data (41). Despite the significant prog-
ress in the elucidation of the WT-20 conformation in lipid
bilayers, it remains unclear at molecular level how the FPs
stabilize more negative Gaussian curvatures and bring about
a substantial reduction of the Im3m and Pn3m lattice param-eters. Because the respective IPMS consist of saddle points
with equal in magnitude and opposite in sign principal
curvatures (resulting in zero mean curvature), one may spec-
ulate that the FPs create local directionality at the membrane
surface such that the lipid monolayer bends in opposite
directions along the peptide contour and in a perpendicular
to it direction. Considerations of the molecular interactions
of basic arginine residues with the lipid surface groups have
led to the conclusion that cell-penetrating arginine-rich
peptides can generate positive curvature along their length
and negative curvature in perpendicular direction, thus
promoting negative Gaussian curvature and formation of
a Pn3m cubic phase (42). Although these considerations
do not appear to be directly applicable to the FPs studied
in this work, it is thinkable, for example, that the rigid
V-shaped conformation of WT-20 might be instrumental
in promoting a positive monolayer curvature along the
peptide contour, in combination with negative curvature
(membrane wrapping around the peptide) in perpendicular
direction. Such a picture would be consistent with the
observed smaller effects of the mutant FPs, which likely
result from a destabilized V-shape as discussed previously,
and with the gradual decrease of the cubic phase lattice
parameter with increase of the FP concentration. However,
it is appropriate to note that, besides the fusion peptides,
a number of other peptides, e.g., pore-forming antimicrobial
peptides were also found to promote cubic phase formation
(43–47). It would be of significant interest to compare the
structures of the different peptides known to induce cubic
phases with the hope of distinguishing whether these
peptides generate negative Gaussian curvatures by a unique
or by different molecular mechanisms.
At temperatures below the onset of HII and QII phase
formation, we observed La phase disordering (loss of corre-
lation between adjacent bilayers and La unbinding) in
DOPE-Me mixtures with WT-20, but not with the G1E
and G13L mutants. The WT-20 peptide induced almost
complete disordering of the La phase in DOPE-Me, fol-
lowed by facile conversion into the inverted cubic phase
(Fig. 7 C), whereas the mutant peptides G1E and G13L
had much smaller effects (Fig. 8). In a previous study, we
showed that unbinding of the La phase is an important factor
in facilitating inverted cubic phase formation (28). An La
phase disordering was also found in mixtures of supported
dioleoyl phosphatidylcholine (DOPC) multilayers with
HIV-1 fusion peptide (48,49). It was argued that the
disordering of the DOPC La phase could be due either to
electrostatic repulsion between the bilayers resulting from
uncompensated surface charge introduced by the peptide
molecules, or to a repulsive force arising from increased
out-of-plane membrane undulations, seen as deriving from
a decreased membrane bending modulus. The present com-
parative study of three different peptides provides some
clues about the origin of the unbinding effect. Taking note
of the much stronger disordering effect of WT-20 versusBiophysical Journal 104(5) 1029–1037
1036 Tenchov et al.the mutant peptides on the La phase, it appears unlikely that
the La phase disordering of DOPE-Me is due to electrostatic
repulsion. An electrostatic repulsive term should be the
same for WT-20 and G13L, which have identical ionization
states, or even stronger for G1E than for WT-20 due to an
additional ionized group in the G1E mutant. It is similarly
unlikely that unbinding could result from steric hindrance
created by peptide chains occupying space at the membrane
interface. If present, a steric repulsion term could be ex-
pected to be of the same magnitude or even greater for the
mutant peptides and would thus not explain why only
WT-20 disorders the lamellar phase. On the other hand,
WT-20 might have a stronger effect on the membrane
mechanical properties than G1E and G13L due to its pre-
sumably deeper hydrophobic penetration. Thus, we believe
that repulsion arising from out-of-plane membrane fluctua-
tions induced by WT-20 is a more probable cause of the La
phase unbinding than electrostatic or steric repulsion. If so,
the La phase disordering induced in DOPC by HIV-1 fusion
peptide (48,49) and in DOPE-Me by WT-20 may have
a similar origin in a peptide-induced decrease of the bending
energy.
The La phase disordering may also involve formation of
QII phase precursors (fusion pores) at temperatures below
the onset of the La-QII phase transformation. Lamellar
phase disordering occurs also in pure DOPE-Me at temper-
atures in the range of the latter transition either during slow
heating scans (26), or at constant temperature incubation
(28,29). However, because WT-20 strongly favors QII at
the expense of the lamellar phase, it must also facilitate
formation of fusion pores at lower temperatures. Thus,
one function of the fusion peptide in influenza HA-induced
fusion may be to stabilize the fusion product by expanding
to lower temperatures the temperature range in which fusion
between bilayers can take place.CONCLUSIONS
The present XRD study revealed a strong influence of
N-terminal influenza hemagglutinin fusion peptides on the
formation of inverted nonlamellar phospholipid phases.
Measurements on phospholipid mixtures with the wild-
type WT-20 peptide or its mutants G1E and G13L showed
that the fusion peptides promote formation of cubic phases
with substantially reduced lattice constant, which become
inserted between the La and HII phases. The cubic phase
formation is favored at the expense of both La and HII
phases.
The effects of WT-20 are notably stronger than those of
the G1E and G13L peptides. At a lipid/peptide molar ratio
of 50:1, the WT-20 peptide completely abolishes the HII
phase and brings about almost complete unbinding of the
La phase in DOPE-Me dispersions, followed by its facile
replacement with a Pn3m cubic phase. The data suggest
that the fusion-competent WT-20 peptide may act specifi-Biophysical Journal 104(5) 1029–1037cally by favoring membrane states of more negative
Gaussian curvature and promoting fusion along pathways
involving inverted cubic (Pn3m) phase-like structures rather
than pathways involving inverted hexagonal phase-like
structures. The stronger effects of WT-20 in comparison to
the effects of the G1E and G13L mutant peptides appear
to be due to its deeper penetration into the hydrophobic
membrane core.
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